Heartflow (NASDAQ:HTFL) Hits New 12-Month High – Time to Buy?

Shares of Heartflow, Inc. (NASDAQ:HTFL) reached a new 52-week high on Friday . The company traded as high as $47.95 and last traded at $46.80, with a volume of 1989666 shares traded. The stock had previously closed at $45.53.

Analyst Upgrades and Downgrades

HTFL has been the subject of a number of research reports. Wells Fargo & Company lifted their price objective on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Benchmark reissued a “buy” rating on shares of Heartflow in a report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. boosted their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Finally, Piper Sandler reiterated an “overweight” rating and set a $45.00 price objective (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.43.

Heartflow Trading Up 2.8%

The stock has a fifty day moving average of $30.33 and a 200-day moving average of $28.17. The firm has a market capitalization of $4.07 billion and a price-to-earnings ratio of -25.57.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm had revenue of $64.08 million during the quarter. Heartflow’s revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, equities research analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Insider Activity at Heartflow

In related news, CEO John C.M. Farquhar sold 32,676 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $45.00, for a total value of $1,470,420.00. Following the transaction, the chief executive officer owned 388,044 shares in the company, valued at approximately $17,461,980. This represents a 7.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the transaction, the insider directly owned 86,459 shares in the company, valued at approximately $3,564,704.57. The trade was a 9.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 164,041 shares of company stock valued at $5,727,636. 7.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. acquired a new stake in Heartflow in the 3rd quarter valued at $48,871,000. Legal & General Group Plc bought a new position in shares of Heartflow during the third quarter valued at $59,000. Franklin Resources Inc. bought a new stake in Heartflow during the 3rd quarter worth approximately $10,829,000. UBS Group AG bought a new stake in Heartflow during the 3rd quarter worth approximately $5,130,000. Finally, Sei Investments Co. acquired a new stake in Heartflow during the 3rd quarter valued at $303,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.